BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21245676)

  • 1. Organized colorectal cancer screening programmes: how to optimize efficiency in the general population.
    Calazel-Benque A; Viguier J; Roussel C; Pivot X; Eisinger F; Blay JY; Coscas Y; Morère JF
    Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S20-5. PubMed ID: 21245676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organized colorectal cancer screening programmes: how to optimize efficiency among general practitioners.
    Viguier J; Calazel-Benque A; Eisinger F; Pivot X
    Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S26-32. PubMed ID: 21245677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer screening in women aged 50-74 years: is there room for improvement?
    Morère JF; Pivot X; Viguier J; Blay JY; Calazel-Benque A; Coscas Y; Roussel C; Eisinger F
    Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S8-S12. PubMed ID: 21245683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Would general practitioners support a population-based colorectal cancer screening programme of faecal-occult blood testing?
    Tong S; Hughes K; Oldenburg B; Del Mar C
    Intern Med J; 2004; 34(9-10):532-8. PubMed ID: 15482265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer screening: reaching the limits or terra incognita? Lessons from the EDIFICE surveys.
    Eisinger F; Roussel C; Morère JF; Viguier J
    Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S42-4. PubMed ID: 21245681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for prostate cancer: growth without control.
    Eisinger F; Blay JY; Pivot X; Morère JF; Coscas Y; Calazel-Benque A; Roussel C; Viguier J
    Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S33-5. PubMed ID: 21245678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eliciting population preferences for mass colorectal cancer screening organization.
    Nayaradou M; Berchi C; Dejardin O; Launoy G
    Med Decis Making; 2010; 30(2):224-33. PubMed ID: 19692710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large population survey: strengths and limits. Methodology of the EDIFICE survey.
    Roussel C; Touboul C
    Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S5-7. PubMed ID: 21245682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Colorectal cancer screening: a survey of French general practitioners].
    Denis B; Perrin P; Cailleret AF; Guth F; Ruetsch M; Strentz P
    Gastroenterol Clin Biol; 2003 Nov; 27(11):992-7. PubMed ID: 14732845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing epidemiology of colorectal cancer and its relevance for adapting screening guidelines and methods.
    Rozen P; Liphshitz I; Barchana M
    Eur J Cancer Prev; 2011 Jan; 20(1):46-53. PubMed ID: 21102339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of general practitioners' sex and age on systematic recommendation for cancer screening.
    Eisinger F; Pivot X; Coscas Y; Viguier J; Calazel-Benque A; Blay JY; Roussel C; Morère JF
    Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S39-41. PubMed ID: 21245680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer screening in first-degree relatives of colorectal cancer: participation, knowledge, and barriers against screening.
    Gimeno García AZ; Quintero E; Nicolás Pérez D; Hernández M; JiménezSosa A
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1165-71. PubMed ID: 21989122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public awareness of colorectal cancer and screening in a Spanish population.
    Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Jiménez-Sosa A
    Public Health; 2011 Sep; 125(9):609-15. PubMed ID: 21794885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of breast cancer screening in women aged over 75 years: a controversy to come?
    Eisinger F; Viguier J; Blay JY; Morère JF; Coscas Y; Roussel C; Pivot X
    Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S13-5. PubMed ID: 21245673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test.
    van Rijn AF; van Rossum LG; Deutekom M; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
    J Public Health (Oxf); 2008 Dec; 30(4):461-5. PubMed ID: 18716047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
    Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ
    Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Round one of the Adelaide and Meath Hospital/Trinity College Colorectal Cancer Screening Programme: programme report and analysis based on established international key performance indices.
    McNamara D; Qasim A; Lee N; Condon C; O'Morain C
    Ir J Med Sci; 2011 Jun; 180(2):549-52. PubMed ID: 21264524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
    Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer screening attitudes and practices preferences for decision making.
    Messina CR; Lane DS; Grimson R
    Am J Prev Med; 2005 Jun; 28(5):439-46. PubMed ID: 15894147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes, knowledge and practice of CRC screening among GPs in Queensland.
    Youl PH; Jackson C; Oldenburg B; Brown C; Dunn J; Aitken J
    Aust Fam Physician; 2006 Jul; 35(7):547-50. PubMed ID: 16820832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.